Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novartis discloses new protein kinase inhibitors

Feb. 7, 2012

Wilex receives grant for PI3K inhibitor

Feb. 7, 2012

Molecular Insight Pharmaceuticals to evaluate targeted radiopharmaceutical for prostate cancer

Feb. 7, 2012

Temsirolimus shows limited activity in refractory metastatic urothelial cancer

Feb. 7, 2012

Pilot study assesses veliparib/temozolomide combination in metastatic CRPC

Feb. 7, 2012

High-grade glioma combination therapy enters new trial in U.S.

Feb. 7, 2012

FDA advisory committee sets date to review Marqibo NDA

Feb. 6, 2012

FDA accepts IND for Ziopharm product

Feb. 6, 2012

Alpharadin available through new expanded access program

Feb. 6, 2012

Phase II trial assesses RO-4929097 in prostate cancer

Feb. 6, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...